Закажите звонок



Ваша заявка успешно отправлена. В ближайшее время с Вами свяжется наш специалист.

List of publications for


European Science Review, Issue 9-10/2016

Effect of lipid peroxidation on severity of clinical course and recurrence of aphthous stomatitis

DOI: https://doi.org/10.29013/ESR-16-9.10-60-63

Pages: 60 - 63

Authors: Alimova D. M.

Abstract: A study to assess lipid peroxidation oral fluid and blood serum in 110 patients with recurrent aphthous stomatitis of varying severity in the periods of exacerbation and remission. The period of convalescence in patients with RAS clinical course of moderate and severe saved local and systemic imbalance in the system POL-AOS, which is a factor in determining the severity of the clinical course and risk of recurrence. The research results indicate the need for antirecurrent treatment of patients with RAS in the period of remission of clinical manifestations in the mucous

Keywords: recurrent aphthous stomatitis; peroxide oxidation of lipid; antioxidant; malondialdehyde; superoxide dismutase.

1. Akman A., Kacaroglu N., Donmez L., Bacanli A. Relationship between periodontal findings and Behfet’s disease: a controlled
study//J. Clin. Periodontal. – 2007, – N 6 – P. 485–491.
2. Barer G.M, Ionov V. V. Features processes peroxidation at cavity mouth at chronic recurrent aphthous stomatitis//Sa thedra. – 2007. –
Vol. 6, – № 3. – S.42–45.
3. Belyaev A.N, Rygin E.A, Zakhvatova A. N. Systemic and regional anti-oxidant therapy//Surgery. – 2007. – № 11 – P. 24–28.
4. Borisenko L. G. Features in the prevalence of oral mucosal diseases in the population of older age groups//Dental Journal, – 2003, –
number 3 – P. 9–11.
5. Bulkin N.V, Tokmakova E.V Meleshina O.V, Lomakin D. O. Modern aspects of pathogenesis and treatment of chronic recurrent aphthous
stomatitis//Basic Research. – 2012. – № 4 (part 1). – P. 30–33.
6. Chesnokov N.V Ponukalina, E.V, Bazenkova M. N. Activation of free radical oxidation – an effective link of typical pathological processes.
– Saratov: – 2006. – S. –4–10, – P. 20–25, 45–55.
7. Ionov V. V. Status of local immunity, free radical processes, antioxidant protection in chronic recurrent aphthous stomatitis: Avtoref.
dis. …Candidate of medical sciences. – M., – 2008. – P. 22.
8. Kamilov Kh. P., Shukurova U. A. Clinical evaluation of chronic aphtous stomatitis on the index of general severity: Guidelines. – Tashkent,
– 2008. – P.16.
9. Koybasi S., Parlak A. H., Serin E. Recurrent aphthous stomatitis: investigation of possible etiologic factors//Am. J. Otolaryngol – 2006. –
Vol.27, – N4 – P. 229–232.
10. Marchini L., Campos M. S., Silva A. M. et al. Bacterial diversity in aphthous ulcers//Oral Microbiol. Immunol. – 2007, – N 4, – P.
The program of cochlear implantation in children with profound hearing loss in the republic of Uzbekistan («Uzbek model»)
11. Rabinovich O. F., Rabinovich I. M. Clothiers E.A Recurrent aphthous stomatitis: classification, clinical forms and treatment//Dentistry.
– 2010. – № 3. – S. 76–79.
12. Safronova L. A., Poltavs’kyi O. M. Tsaruk’ianova I. H. et al.Oral cavity microbial coenobia in healthy children and children with chronic
recurrent aphthous stomatitis//Mikrobiol. – Z. – 2003, – N 6. – P. 49–58.
13. Sologub T.V, Romantsov M. L. Flint NV Free-radical processes, clinical and theoretical aspects. – Moscow, – 2008. – P. 74–122.
14. Solomon L. W., Neiders M. E., Zwick M. G. Autoimmunity to delta Np63alpha in chronic ulcerative stomatitis//J. Dent. Res. – 2007, –
N 9, – P. 826–831.
15. Sulka A., Simon K., Piszko P. et al. Oral mucosa alterations in chronic hepatitis and cirrhosis due to HBV or HCV infection//Bull
Group Int. Rech. Sci.
16. Tani H., Komoda Y., Matsuo E. et al. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope
proteins//J. Virol. – 2007, – N 6, – P. 8601–8612.
17. Torgerson R. R., Davis M. D., Bruce A.J et al. Contact allergy in oral disease//J. Am. Acad. Dermatol. – 2007, – N 2, – P. 315–321.
18. Zribi H., Crickx B., Descamps V. Prevention of recurrent apthous stomatitis by efalizumab/Raptiva//J. Eur.Acad. Dermatol.Venerol. –
2007. – Vol.1, – N9. – P.1286–1287.